REITHERA SRL, THE RAGON INSTITUTE AND IAVI ANNOUNCE COLLABORATION TO ADVANCE HIGHLY NETWORKED T CELL HIV VACCINE CANDIDATE TOWARDS PHASE I CLINICAL EVALUATION
Feb 5, 2024 Features
Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by The Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to prevention options ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration […]